SOLICITATION NOTICE
66 -- OxyCycler A420C Oxygen C02 Dual Chamber Controller
- Notice Date
- 9/3/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Nat'l Institute of Diabetes, Digestive, & Kidney Diseases, 2 Democracy Plaza, Suite 700W, 6707 Democracy Blvd., MSC 5455, Bethesda, Maryland, 20892-5455
- ZIP Code
- 20892-5455
- Solicitation Number
- NIHLM2015643
- Archive Date
- 9/8/2015
- Point of Contact
- V. Lynn Griffin, Fax: 301-480-8501, MAXWELL KIMPSON,
- E-Mail Address
-
griffinv@mail.nih.gov, Max.Kimpson@nih.gov
(griffinv@mail.nih.gov, Max.Kimpson@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NIHLM2015643 and is issued as a Request for Quotation (RFQ). The solicitation /contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-82. The North American Industry Classification (NAICS) Code is 334516 with a size standard of 500. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13 as supplemented by FAR Part 12 - Commercial Items. The National Institutes of Health (NIH), National Institute of Digestive, Diabetes & Kidney Diseases (NIDDK) has a requirement to procure a OxyCycler A420C Oxygen C02 Dual Chamber Controller. A420C2 OxyCycler A420C Oxygen C02 Dual Chamber Controller Package CUSA30274P GUS Animal Chamber Medium Opaque Polypropylene - 35" to Accommodate 3 Rat Cages - Same Size Door PCL PC Laptop (NIC Included) WATSOFT OxyCycler PC Operator Interface Software USBCONVERT Communication Converter Kit USB RS485 COMMCAB2 Communication Cable DSUB9 DSUB9 CS11 Cord Set North America For many years, the primary focus of our research has been on the genetic diseases of hemoglobin, including sickle cell anemia and thalassemia. More recently, the Branch had broadened its research to include other diseases of the erythroid lineage, as well as a variety or cardiovascular conditions in which regulation of blood flow via NO and other signaling molecules could have important therapeutic consequences. Most of the work is laboratory-based, but Branch members are also active investigators in multiple clinical protocols. Such clinical studies are paired with matching laboratory programs and relate to a number of areas, including: (1) developing biomarkers to predict the severity of sickle cell disease and the etiology of acute and chronic pain as part of this condition, (2) understanding the regulation of fetal hemoglobin expression during development, (3) studying the effects of erythropoietin and other signalling molecules in erythroid cells, and (4) determining the interactions of intracellular and plasma hemoglobin with NO and nitrite ions in physiology and pathology. The Branch has expanded this final area or research to a collaboration with the Clinical Center animal facility and jointly we will measure nitrite and nitrate ions in the blood of animals equilibrated with various 02 and C02 concentrations ins several cages so that we can relate the biochemical and physiological (including blood clotting) processes. This is the first time we have ordered this apparatus, which we expect to use for the next several years. The system shall provide efficient N2 and 02 gas consumption and maintain constant oxygen with a regulated tolerance of 02 tension within 0.1 %, particularly for the planned studies at normoxia (20% 02) and reduced (10% 02) oxygen environments. Custom size chambers must be available for animals of different sizes such as rats and mice. Regulate ventilation must be available for air quality and use of gas in chamber, particularly for the duration of exercise studies over several hours with regulated humidity and removal of exhaled gasses and waste vapors. The chamber shall be polypropylene and provide a constant gas environment from extreme hypoxia (0.1 % 02) to hypoxia (99.9% 02). The system shall allow upgrade to incorporate additional gasses. The requirement listed is requested to submit a capability statement to assist the Government in determining in accordance with Federal Acquisition Regulation (FAR) 19.502-2(b) whether or not this procurement will be set-aside for any of the programs described above. The intended procurement will be classified under North American Industrial Classification (NAICS) code 334516 with a size standard 500. All respondents are requested to identify their firm's size and type of business. Interested firms responding to this market survey must provide (a) capability statement demonstrating their experience, skills and capability to fulfill the Government's requirements for the above. The capability statement shall be in sufficient enough detail, but not to exceed 15 pages, so that the Government can determine the experience and capability of your firm to provide the requirements above. Your capability statement, not to exceed 15 pages, should include references. The offeror must include a completed copy of the following provisions: 1) FAR Clause 52.212-1 Instructions to Offerors - Commercial items; 2) FAR Clause 52.212-2, Evaluation - Commercial Items. As stated in FAR Clause 52.212-2 (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be advantageous to the Government, price and other factors considered. The following factors will be used equally to evaluate offers: Technical Evaluation, Price, and Past Performance. Note: Past Performance Information: Vendors must submit a listing of the most recent contracts/awards (minimum of 3) which demonstrate similar work in nature to this Solicitation. Contracts/awards may include those entered with the Federal Government, state and local governments and commercial concerns. Include the following information for each contract or subcontract: 1.Name of Contracting Organization 2.Contract Number (for subcontracts provide the prime contract number and the subcontract number) 3.Contract Type 4.Total Contract Value 5.Description of Requirement 6.Contracting Officer's Name and Telephone Number 7.Program Manager's Name and Telephone Number 3) FAR Clause 52.212-3, Offeror Representations and Certifications - Commercial Items; 4) FAR Clause 52.212-4, Contract Terms and Conditions - Commercial Items; 5) FAR Clause 52-212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items - Deviation for Simplified Acquisitions. The Dun and Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN) and the certification of business size shall be included. The clauses are available in full text at https://www.acquisition.gov PLEASE NOTE: In order to receive an award, contractor must be registered and have valid certification in the System For Award Management (SAM) http://www.sam.gov Interested vendors capable of providing the Government with the items specified in this synopsis should submit their quotation to the below address. Quotations will be due on or before September 7, 2015 at 11:00 a.m. EST. Offersors shall provide an original and one copy of your quotation. The quotation must reference Solicitation number NIHLM2015634. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Responses: E-MAIL will be accepted and can be sent to griffinv@mail.nih.gov and must reference solicitation number NIHLM2015643 in the subject line.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDDKD/NIHLM2015643/listing.html)
- Record
- SN03871837-W 20150905/150904001119-40412a87a98cd4abb36f9c2b5f247b7a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |